(Dis)similar Analogues of Riboswitch Metabolites as Antibacterial Lead Compounds
- 3 February 2015
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (8) , 3275-3286
Abstract
The rise of antimicrobial resistance in human pathogenic bacteria has increased the necessity for the discovery of novel, yet unexplored antibacterial drug targets. Riboswitches, which are embedded in untranslated regions of bacterial messenger RNA (mRNA), represent such an interesting target structure. These RNA elements regulate gene expression upon binding to natural metabolites, second messengers, and inorganic ions, such as fluoride with high affinity and in a highly discriminative manner. Recently, efforts have been directed toward the identification of artificial riboswitch activators by establishing high-throughput screening assays, fragment-based screening, and structure-guided ligand design approaches. Emphasis in this review is placed on the special requirements and synthesis of new potential antibiotic drugs that target riboswitches in which dissimilarity is an important aspect in the design of potential lead compounds.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR 854, Ma 3442/2-2)
This publication has 97 references indexed in Scilit:
- Riboswitch-based antibacterial drug discovery using high-throughput screening methodsExpert Opinion on Drug Discovery, 2012
- Dual-acting riboswitch control of translation initiation and mRNA decayProceedings of the National Academy of Sciences, 2012
- Riboswitch control of Rho-dependent transcription terminationProceedings of the National Academy of Sciences, 2012
- Prospects for Riboswitch Discovery and AnalysisMolecular Cell, 2011
- Riboswitches: Discovery of Drugs That Target Bacterial Gene-Regulatory RNAsAccounts of Chemical Research, 2011
- A trans-Acting Riboswitch Controls Expression of the Virulence Regulator PrfA in Listeria monocytogenesCell, 2009
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Riboswitches as antibacterial drug targetsNature Biotechnology, 2006
- Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expressionNature, 2002
- The S box regulon: a new global transcription termination control system for methionine and cysteine biosynthesis genes in Gram‐positive bacteriaMolecular Microbiology, 1998